STLN · Company research
Starling Oncology, Inc. Common Stock (STLN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableOther
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 6.58 | $670,735,019.43 | 629641019.43 | 44.2000000000000000 | — | — | — | — | 60.79904092005076142000 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.